Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Multimodal Physiologic Signal Fusion for 72-Hour Prediction of Acute Clinical Deterioration

Authors not listed

Truway Health, Inc. · 2026

Abstract

Rather than relying on a single abnormal vital sign, the study will examine how multiple physiologic signals change together over time and whether changes in the relationships among these signals provide useful information about impending clinical deterioration. Individual participant physiologic patterns may be characterized longitudinally to account for differences between individuals and changes within the same individual over time. The primary objective is to evaluate the predictive accuracy of multimodal digital biomarkers for protocol-defined acute clinical deterioration occurring within 72 hours. The study is observational and does not assign participants to an investigational treatment.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Anonymous. (2026). Multimodal Physiologic Signal Fusion for 72-Hour Prediction of Acute Clinical Deterioration. <em>Truway Health, Inc.</em>. https://clinicaltrials.gov/study/NCT07817550
Vancouver
Anonymous. Multimodal Physiologic Signal Fusion for 72-Hour Prediction of Acute Clinical Deterioration. Truway Health, Inc.. 2026.
BibTeX
@misc{anon2026Multim, title = {Multimodal Physiologic Signal Fusion for 72-Hour Prediction of Acute Clinical Deterioration}, author = {Anonymous}, journal = {Truway Health, Inc.}, year = {2026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings